In addition, based on previous studies showing that psychological factors are closely related to the pathogenesis of FD [12,33,34], we will measure HADS as a secondary outcome to determine whether anxiety and depressive symptoms are improved after administration of investigational products and to examine the correlation with other outcomes such as TDS and ghrelin. The gene discussed is GHRL; the disease is Fabry disease.